Philadelphia, PA, United States of America

Anna Tretiakova

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Regenxbio Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Anna Tretiakova in the Field of Medicine.

Introduction

Anna Tretiakova is an accomplished inventor based in Philadelphia, PA. She has made significant contributions to the field of medicine, particularly in the treatment of age-related conditions. Her innovative work has led to the development of a patent that addresses a critical health issue.

Latest Patents

Anna holds a patent for "Compositions for Treatment of Wet Age-Related Macular Degeneration." This invention aims to provide effective solutions for individuals suffering from this debilitating condition. Her dedication to improving patient outcomes is evident in her research and development efforts.

Career Highlights

Anna Tretiakova is associated with Regenxbio Inc., a company known for its advancements in gene therapy. Her role at the company has allowed her to work on groundbreaking projects that have the potential to transform treatment methodologies in ophthalmology.

Collaborations

Throughout her career, Anna has collaborated with notable professionals in her field, including Jean Bennett and Albert M. Maguire. These partnerships have fostered an environment of innovation and have contributed to the success of her projects.

Conclusion

Anna Tretiakova's contributions to medical science through her patent and collaborations highlight her commitment to advancing healthcare solutions. Her work continues to inspire future innovations in the treatment of age-related diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…